HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Study summary

This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedBest Practice and Educational Intervention

Plus 3 other study approaches.

Who it may be forBreast Carcinoma · Colorectal Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 11, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?City of Hope Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: City of Hope Medical Center
Interventions being studied: Other: Best Practice; Other: Educational Intervention; Other: Educational Intervention; Procedure: Genomic Profile; Other: Survey Administration

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Are enrolled in City of Hope (COH) Institutional Review Board (IRB) 07047
Have a diagnosis of lung, breast, colorectal, pancreatic, ovarian or prostate cancer
Having somatic, germline or paired somatic/germline sequencing
Are fluent in English
Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
Are \>= 18 years old

Reasons someone may not be able to joinExclusion criteria

Are unable to provide informed consent

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

City of Hope Medical CenterDuarte, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 11, 2026. Always confirm current availability with the study team.

View original record ↗